Compare RGC & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | DCI |
|---|---|---|
| Founded | 2014 | 1915 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.7B |
| IPO Year | 2020 | 2005 |
| Metric | RGC | DCI |
|---|---|---|
| Price | $28.69 | $89.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $99.00 |
| AVG Volume (30 Days) | 155.5K | ★ 480.3K |
| Earning Date | 10-31-2025 | 06-02-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $2,844,900,000.00 |
| Revenue This Year | N/A | $4.58 |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | ★ N/A | $50.83 |
| Revenue Growth | N/A | ★ 4.05 |
| 52 Week Low | $9.39 | $63.71 |
| 52 Week High | $950.00 | $112.84 |
| Indicator | RGC | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 50.46 |
| Support Level | $22.43 | $88.50 |
| Resistance Level | $35.67 | $94.26 |
| Average True Range (ATR) | 3.52 | 1.81 |
| MACD | -0.12 | 0.66 |
| Stochastic Oscillator | 22.07 | 75.74 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.